HeartBeam Inc. (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses. The transaction was completed on April 16, 2026, and was supported by key stakeholders including ClearCardio, company leadership, and institutional investors.
The proceeds will fund the commercialization of HeartBeam’s FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection technologies, expansion of AI capabilities, and general corporate purposes. The company’s platform technology is designed for portable devices that can collect ECG signals in 3D from three non-coplanar directions and synthesize them into a 12-lead ECG, enabling physicians to identify cardiac health trends and acute conditions outside of a medical facility.
HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, and its 12-lead ECG synthesis software received clearance in December 2025. The company holds over 20 issued patents related to technology enablement. For more details on the intended use of its technology, refer to the company’s Cleared Indications for Use at https://www.heartbeam.com/indications.
The successful capital raise comes as HeartBeam advances toward commercializing its cable-free, portable ECG system. The funding will accelerate the company’s efforts to bring its technology to market, potentially expanding access to cardiac monitoring for patients outside traditional clinical settings. The offering also underscores investor confidence in HeartBeam’s approach to cardiac health management.
HeartBeam is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The company’s platform is designed to deliver actionable heart intelligence wherever the patient is, redefining the future of cardiac health management. For the latest news and updates relating to BEAT, visit the company’s newsroom at https://ibn.fm/BEAT.
